ALNY
$ALNY
Alnylam Pharmaceuticals, Inc.
Pioneer in RNA interference therapeutics treating rare genetic diseases.
Healthcare$333.00
+10.89 (+3.38%)
Day Range$319.00 - $333.56
Prev Close$322.11
Analyst Rating
Strong Buy
27 Buy / 9 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Apr 19
Weekly updates
Latest Report
ALNY: RNAi Growth Meets Clinical Momentum
Alnylam ($ALNY) is showing renewed momentum after positive vutrisiran data and a technical breakout. Strong analyst coverage and solid fundamentals support upside, though valuation and policy risk warrant caution.
Apr 6, 2026